CBDG (THC Farmaceuticals) EBITDA Margin %: -100.00% (As of Jun. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is THC Farmaceuticals EBITDA Margin %?

THC Farmaceuticals CBDG EBITDA Margin % is -100.00% as of Jun. 2018.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. THC Farmaceuticals's EBITDA for the three months ended in Jun. 2018 was $-0.00 Mil. THC Farmaceuticals's Revenue for the three months ended in Jun. 2018 was $0.00 Mil. Therefore, THC Farmaceuticals's EBITDA margin for the quarter that ended in Jun. 2018 was -100.00%.

THC Farmaceuticals  (OTCPK:CBDG) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

THC Farmaceuticals EBITDA Margin % Related Terms

THC Farmaceuticals EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for THC Farmaceuticals's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Farmaceuticals EBITDA Margin % Chart

THC Farmaceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13
EBITDA Margin %
-3.45 -50.00 -119.35 -86.36

THC Farmaceuticals Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Mar17 Jun17 Mar18 Jun18
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -700.00 -25.00 -66.67 -25.00 -100.00

CBDG vs BOXS: EBITDA Margin % Comparison

For the Biotechnology subindustry, THC Farmaceuticals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

THC Farmaceuticals EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, THC Farmaceuticals's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where THC Farmaceuticals's EBITDA Margin % falls into.


THC Farmaceuticals EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

THC Farmaceuticals's EBITDA Margin % for the fiscal year that ended in Sep. 2013 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2013 )/Revenue (A: Sep. 2013 )
=-0.019/0.022
=-86.36 %

THC Farmaceuticals's EBITDA Margin % for the quarter that ended in Jun. 2018 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2018 )/Revenue (Q: Jun. 2018 )
=-0.002/0.002
=-100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -100.00% mean?
THC Farmaceuticals (CBDG) has a EBITDA Margin % of -100.00% as of Jun. 2018. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on THC Farmaceuticals and its competitors.
Is THC Farmaceuticals' EBITDA Margin % too high?
THC Farmaceuticals' current EBITDA Margin % is -100.00%.
How does THC Farmaceuticals' EBITDA Margin % compare to BOXS?
THC Farmaceuticals' EBITDA Margin % of -100.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on THC Farmaceuticals and its competitors. THC Farmaceuticals's current EBITDA Margin % is -100.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THC Farmaceuticals stock overvalued right now?
THC Farmaceuticals (CBDG) has a current EBITDA Margin % of -100.00%. The current EBITDA Margin % is -100.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For THC Farmaceuticals (CBDG), the current EBITDA Margin % is -100.00% as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

THC Farmaceuticals Business Description

Address 2789 Rio Vista Drive, Suite 3, Saint George, UT, USA, 84790
THC Farmaceuticals Inc is a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology, and other medical disciplines. It offers the combination of proprietary developments with the expertise of clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds.